VAERS Explorer
Back to explore

Report #2837950

Received Apr 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
PA
Recovered
Unknown
Vaccinated
Apr 17, 2025
Onset
Apr 17, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKX010523—

Symptoms (1)

Expired product administered

Symptom narrative

the patient involved has not experienced any medical concerns or symptoms after being administered the expired VARIVAX; Medical Assistant calling to report an adverse event regarding an expired administration of VARIVAX. Medical Assistant stated that a dose of VARIVAX with a labeled expiration date of 4/11/2025 was administered to a patient today, 4/17/2025. Medical; This spontaneous report was received from a Medical Assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 17-Apr-2025, the patient was vaccinated with an expired dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) lot #X010523, expiration date: 11-Apr-2025, 0.5 mL (0.5 mL / Two dose series) (strength, route, and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (details not provided). Medical Assistant confirmed the patient involved has not experienced any medical concerns or symptoms after being administered the expired Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX).

Other medications

Sterile diluent